Neuroepigenetic disorders: progress, promises and challenges

Neuropharmacology. 2014 May:80:1-2. doi: 10.1016/j.neuropharm.2014.02.013. Epub 2014 Feb 27.

Author

Affiliation

¹ Instituto de Neurociencias, CSIC-UMH, Molecular Neurobiology Unit, Avda. Santiago Ramon y Cajal s/n, San Juan de Alicante 03550, Alicante, Spain. Electronic address: abarco@umh.es.

PMID: 24582886
DOI: 10.1016/j.neuropharm.2014.02.013

No abstract available

Publication types

Editorial
Introductory Journal Article

MeSH terms

Animals
Brain / drug effects
Brain / metabolism
Chromatin / drug effects
Chromatin / metabolism
Chromatin Assembly and Disassembly* / drug effects
DNA Methylation / drug effects
Epigenesis, Genetic* / drug effects
Epigenomics / methods
Epigenomics / trends
Histones / metabolism
Humans
Nerve Tissue Proteins / metabolism
Nervous System Diseases / drug therapy
Nervous System Diseases / metabolism*
Neurobiology / methods
Neurobiology / trends
Neurons / drug effects
Neurons / metabolism*
Neuropharmacology / methods
Neuropharmacology / trends
Protein Processing, Post-Translational / drug effects

Substances

Chromatin
Histones
Nerve Tissue Proteins